A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The MACH Trial is a pilot study of 400mg minocycline over five days in acute intracerebral
hemorrhage patients. The study will evaluation the safety and efficacy of minocycline in
intracerebral hemorrhage patients.